Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd (SZSE:002864) announces a share repurchase program. Under the program, the company will repurchase up to CNY 20 million. The shares will be repurchased at a price not more than CNY 39 per share. The company intends use its own funds for the repurchase program. The purpose of the share repurchases is for implementation of ESOP or equity incentives. The plan will be valid for a period of 12 months.